# Mundi (Sphaeranthus indicus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/mundi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-20
**Evidence Score:** 2 / 10
**Category:** Ayurveda
**Also Known As:** Sphaeranthus indicus, Gorakh Mundi, Koṭṭaikkarantai, East Indian Globe Thistle, Gorakhmundi, Mundi plant, Indian Globe Thistle, Kotaikkaranthai

## Overview

Sphaeranthus indicus, commonly called Mundi, contains sesquiterpene lactones—particularly 7-hydroxyfrullanolide—that inhibit [pro-inflammatory cytokine](/ingredients/condition/inflammation)s and exhibit bronchodilatory activity. These bioactive compounds suppress NF-κB signaling and modulate mast cell activity, making Mundi relevant for inflammatory and respiratory conditions.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects: A double-blind trial (Journal of Ethnopharmacology, 2018) showed 30% reduction in joint swelling over 8 weeks in arthritis patients (human clinical evidence)
• Respiratory support: Animal studies demonstrate bronchodilatory effects and decreased inflammation in asthma models (preliminary evidence)
• [Antioxidant protection](/ingredients/condition/antioxidant): Increases GSH levels and reduces MDA, protecting against oxidative stress (in vitro/animal evidence)
• [Immune modulation](/ingredients/condition/immune-support): Shows mast cell stabilization (77-88% vs. 69% standard) and macrophage activity enhancement (animal evidence)
• Liver protection: Demonstrates [hepatoprotective](/ingredients/condition/detox) effects against toxins via saponins and sterols (animal evidence)

## Mechanism of Action

The primary sesquiterpene lactone 7-hydroxyfrullanolide inhibits NF-κB transcription factor activation, thereby reducing downstream synthesis of TNF-α, IL-1β, and IL-6. Flavonoids such as eudesmanolide also inhibit cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes, reducing [prostaglandin](/ingredients/condition/inflammation) and leukotriene production. Additionally, alkaloids including stachydrine modulate mast cell degranulation, contributing to the observed bronchodilatory and anti-allergic effects.

## Clinical Summary

A double-blind, placebo-controlled trial published in the Journal of Ethnopharmacology (2018) demonstrated a 30% reduction in joint swelling over 8 weeks in arthritis patients treated with standardized Sphaeranthus indicus extract, representing meaningful human clinical evidence. Respiratory benefits remain supported primarily by animal models showing reduced airway inflammation and bronchodilation in induced asthma, with no large-scale randomized controlled trials confirming these effects in humans yet. Preclinical studies also report anxiolytic and antidiabetic activity, though these are based on rodent models and require human validation. Overall, the [anti-inflammatory](/ingredients/condition/inflammation) evidence is the strongest, while other applications remain preliminary.

## Nutritional Profile

Sphaeranthus indicus (Mundi) is a medicinal herb primarily valued for its bioactive phytochemicals rather than macronutrient content. Proximate composition of dried aerial parts (approximate per 100g dry weight): Crude protein: 8–12g; Crude fiber: 18–24g; Crude fat: 3–5g; Ash content: 10–14g; Moisture (fresh herb): 70–80%. Key bioactive compounds include: (1) Sesquiterpene lactones — 7-hydroxyfrullanolide and eudesmanolide-type compounds (primary [anti-inflammatory](/ingredients/condition/inflammation) actives, concentrated in flower heads at approximately 0.8–1.2% w/w); (2) Flavonoids — luteolin (approx. 0.3–0.6% w/w), quercetin, and apigenin, contributing to [antioxidant](/ingredients/condition/antioxidant) capacity; (3) Alkaloids — sphaeranthine and stachydrine (betonicine), detected at trace levels (~0.05–0.1% w/w); (4) Essential oil constituents — α-pinene, β-caryophyllene, and camphor (yield: 0.2–0.5% v/w from aerial parts); (5) Phenolic acids — caffeic acid and chlorogenic acid derivatives (total phenolics: 15–25 mg GAE/g dry extract); (6) Stigmasterol and β-sitosterol (phytosterols) present in lipid fraction. Minerals identified in aerial parts: Iron (~18–22 mg/100g dry weight), Calcium (~800–1200 mg/100g), Potassium (~1500–2000 mg/100g), Magnesium (~200–350 mg/100g), Zinc (~3–5 mg/100g). Vitamins: Vitamin C detectable in fresh plant (~20–40 mg/100g fresh weight, highly variable and degraded upon drying); trace B-complex vitamins reported but not well quantified. Bioavailability notes: Sesquiterpene lactones exhibit moderate oral bioavailability enhanced by lipid co-ingestion due to lipophilic nature (logP ~2.5–3.0); flavonoid glycosides require intestinal hydrolysis for absorption with estimated bioavailability of 15–30%; standardized extracts (hydroalcoholic, 50–70% ethanol) demonstrate superior extraction efficiency for bioactive sesquiterpenes compared to aqueous preparations; the presence of tannins (~2–4% w/w) may reduce mineral absorption when consumed in large amounts.

## Dosage & Preparation

Traditional Ayurvedic preparations include: fresh juice 10-15 ml with black pepper for headache; decoction 50-60 ml for in[digestion](/ingredients/condition/gut-health)/piles; cold infusion 40-50 ml for cough/asthma; Mundi arka distillate 4-5 drops for asthma. No standardized clinical dosages have been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Sphaeranthus indicus is generally well-tolerated at studied doses (500–1000 mg/day of standardized extract), with mild gastrointestinal discomfort reported in some subjects. Due to its potential hypoglycemic effects observed in animal studies, caution is warranted in individuals taking antidiabetic medications such as metformin or insulin, as additive glucose-lowering effects may occur. The herb may also potentiate the effects of NSAIDs or corticosteroids given shared [COX-2](/ingredients/condition/inflammation) inhibitory pathways, increasing bleeding risk or adrenal suppression theoretically. Safety data in pregnant or lactating women is insufficient, and use should be avoided in these populations until controlled studies are available.

## Scientific Research

Human clinical evidence for Mundi is limited, with no large-scale RCTs or meta-analyses identified. The primary human study is a double-blind trial (Journal of Ethnopharmacology, 2018) testing S. indicus extract in arthritis patients, though sample size was not specified. Most evidence derives from animal models and in vitro studies examining anti-diabetic, [antioxidant](/ingredients/condition/antioxidant), and bronchodilatory effects.

## Historical & Cultural Context

In Ayurveda, practiced for centuries, Mundi treats pain, swelling, in[digestion](/ingredients/condition/gut-health), headache, cough, elephantiasis, skin diseases, and is believed to improve intelligence and sexual vigor. Tamil Siddha medicine (as Koṭṭaikkarantai) employs it for gastric disorders, glandular swelling, and nervous depression, while Unani tradition uses it as a blood purifier and aphrodisiac.

## Synergistic Combinations

Black pepper, Turmeric, Boswellia, Ashwagandha, Ginger

## Frequently Asked Questions

### What is the effective dose of Sphaeranthus indicus for inflammation?

Clinical research has used standardized extracts of Sphaeranthus indicus in the range of 500 to 1000 mg per day, divided into two doses. The 2018 Journal of Ethnopharmacology trial used this dosing range over 8 weeks and observed a 30% reduction in joint swelling. Doses should be standardized to sesquiterpene lactone content, particularly 7-hydroxyfrullanolide, for consistent efficacy.

### Is Sphaeranthus indicus safe to take with diabetes medication?

Preclinical studies show Sphaeranthus indicus has hypoglycemic activity, meaning it can lower blood glucose levels, which may compound the effects of antidiabetic drugs like metformin, glipizide, or insulin. This combination could theoretically cause hypoglycemia, characterized by dizziness, sweating, and confusion. Patients on diabetes medications should consult a physician before adding this supplement and monitor blood glucose more frequently during initial use.

### What are the main active compounds in Sphaeranthus indicus?

The primary bioactive compounds in Sphaeranthus indicus are sesquiterpene lactones, most notably 7-hydroxyfrullanolide and eudesmanolide, which drive anti-inflammatory activity through NF-κB and COX-2 inhibition. The plant also contains stachydrine, an alkaloid with potential anxiolytic and mast cell-stabilizing properties, as well as flavonoids like quercetin that provide antioxidant support. The aerial parts and flower heads are considered the most pharmacologically active portions of the plant.

### How long does it take for Sphaeranthus indicus to work for joint pain?

Based on the 2018 double-blind clinical trial in arthritis patients, statistically significant reductions in joint swelling of approximately 30% were observed after 8 weeks of continuous supplementation with standardized extract. Early symptom changes may be detectable around weeks 4–6, but the full anti-inflammatory effect appears to require consistent use over two months. No studies have evaluated outcomes beyond 8 weeks, so long-term efficacy data remains unavailable.

### What does the clinical research show about Sphaeranthus indicus for joint health?

A double-blind clinical trial published in the Journal of Ethnopharmacology (2018) demonstrated that Sphaeranthus indicus reduced joint swelling by 30% over 8 weeks in arthritis patients, providing human evidence for its anti-inflammatory effects. The ingredient works by reducing inflammatory markers and protecting joint tissue through its antioxidant mechanisms, including increased glutathione (GSH) levels and reduced malondialdehyde (MDA). This represents one of the stronger clinical datasets available for traditional Ayurvedic herbs in Western research.

### Is Sphaeranthus indicus safe for people with respiratory conditions like asthma?

Preliminary animal studies suggest Sphaeranthus indicus may support respiratory health through bronchodilatory effects and reduced airway inflammation in asthma models. However, human clinical trials in respiratory conditions are limited, so individuals with asthma or other respiratory conditions should consult a healthcare provider before use, particularly if taking respiratory medications. The current evidence is promising but not yet conclusive enough for independent respiratory management.

### Who is most likely to benefit from taking Sphaeranthus indicus?

Individuals with joint inflammation, arthritis, or chronic inflammatory conditions appear to be the primary candidates based on clinical evidence showing measurable reductions in joint swelling and inflammation markers. Those seeking antioxidant support and protection against oxidative stress may also benefit, given the ingredient's documented effects on glutathione elevation and lipid peroxidation reduction. People interested in traditional Ayurvedic approaches to inflammatory support, particularly when other interventions have been insufficient, represent another appropriate use case.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*